Antisense & RNAi Therapeutics Market 2018 Global Share, Trends, Demand, Challenges and Opportunities Research Report Forecast to 2023
Sep 5, 2018
Wiseguyreports.Com Added New Market Research Report On -“Antisense & RNAi Therapeutics Market 2018 Manufacturers, Applications and Future Demand Forecast to 2023 ”.
Pune, India - September 5, 2018 /MarketersMedia/ —
Global Antisense & RNAi Therapeutics Market
WiseGuyRerports.com Presents “Global Antisense & RNAi Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023” New Document to its Studies Database. The Report Contain 152 Pages With Detailed Analysis.
Description
Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene "off".
Scope of the Report:
This report studies the Antisense & RNAi Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antisense & RNAi Therapeutics market by product type and applications/end industries.
Get sample Report @ https://www.wiseguyreports.com/sample-request/3370710-global-antisense-rnai-therapeutics-market-2018-by-manufacturers
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antisense & RNAi Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Glaxo Smith Kline
Sanofi Aventis / Genzyme
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Arbutus Biopharma Ltd.
Silence Therapeutics
Bio-Path Holdings Inc.
Calando Pharmaceuticals
ICo Therapeutics
Quark Pharmaceuticals
Rexhan Pharmaceuticals
Biomarin/Prosensa
Regulus Therapeutics
Rxi Pharmaceuticals
Silenseed
Dicerna Pharmaceuticals
Sirnaomics Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
RNA interference
SiRNA
MiRNA
Antisense RNA
Market Segment by Applications, can be divided into
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases
Complete Report Details @ https://www.wiseguyreports.com/reports/3370710-global-antisense-rnai-therapeutics-market-2018-by-manufacturers
Table of Contents -Major Key Points
1 Antisense & RNAi Therapeutics Market Overview
1.1 Product Overview and Scope of Antisense & RNAi Therapeutics
1.2 Classification of Antisense & RNAi Therapeutics by Types
1.2.1 Global Antisense & RNAi Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Types in 2017
1.2.3 RNA interference
1.2.4 SiRNA
1.2.5 MiRNA
1.2.6 Antisense RNA
1.3 Global Antisense & RNAi Therapeutics Market by Application
1.3.1 Global Antisense & RNAi Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Renal
1.3.5 Neurodegenerative
1.3.6 Respiratory
1.3.7 Genetic
1.3.8 Infectious Diseases
1.4 Global Antisense & RNAi Therapeutics Market by Regions
1.4.1 Global Antisense & RNAi Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Antisense & RNAi Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Glaxo Smith Kline
2.1.1 Business Overview
2.1.2 Antisense & RNAi Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi Aventis / Genzyme
2.2.1 Business Overview
2.2.2 Antisense & RNAi Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
2.3.1 Business Overview
2.3.2 Antisense & RNAi Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Arbutus Biopharma Ltd.
2.4.1 Business Overview
2.4.2 Antisense & RNAi Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Silence Therapeutics
2.5.1 Business Overview
2.5.2 Antisense & RNAi Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Silence Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
……..CONTINUED
Contact Info:
Name: Norah Trent
Email: [email protected]
Organization: WiseguyReports
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)
For more information, please visit http://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 402956
More News
Reliance Consumer launches ₹20 Joyland flavoured milk in Tamil Nadu, plans India rollout
The launch marks the beginning of the company’s plan to build Joyland into a broader dairy beverages portfolio across India.
HD Kumaraswamy seeks CBI probe into alleged sting targeting Karnataka leaders
Union Minister HD Kumaraswamy has requested a CBI investigation into alleged surveillance of political figures in Karnataka. He plans to submit a formal complaint to Home Minister Amit Shah for an independent probe. Kumaraswamy asserts that those involved in the alleged operations should be identified and investigated thoroughly.
Ruben Dias Defends Manchester City's Celebrations Amidst Financial Breach Fallout
"People don't love us winning and we love to win," said Ruben Dias as the Man City skipper defended the club's celebrations after the Liverpool win.
Germany briefly shuts Nuremberg airport, scrambles jets to escort flight from Corfu
Police cordoned off Nuremberg airport in southern Germany and launched an investigation before the commercial plane landed safely from the Greek island of Corfu and authorities issued an all-clear, the agency reported.
China sentences 3 more Myanmar crime bosses to death in scam centre crackdown
Courts in China have sentenced three key figures of a notorious Myanmar crime syndicate to death for operating large-scale cross-border telecoms fraud networks and causing the deaths of four Chinese nationals. The Quanzhou Intermediate People’s Court and the Nanan City People’s Court in southeastern Fujian province handed down the rulings against syndicate head Wei Huairen, his nephew Chen Dawei and accomplice Liao Jingfang on Tuesday, following a trial held in May, state broadcaster CCTV...
School Assembly News Headlines, October 14, 2026: Check national, international, business, sports updates and thought of the day
School assemblies are essential in keeping students updated on crucial happenings both nationally and globally. Recently, the Supreme Court's decision to reschedule hearings regarding protests showcases ongoing legal discussions. The Home Minister of India calls for enhanced regional collaboration to tackle terrorism threats. In the realm of sports, Shubman Gill and Shafali Verma have been celebrated as ICC Players of the Month due to their outstanding achievements.
In 2013, Lakers coach Mike D’Antoni bought an ocean-view California home for $6.9 million; two years later, he sold it for $9.5 million
Mike D'Antoni, the former Los Angeles Lakers coach, bought a home in Manhattan Beach for $6.9 million. He sold this property two years later for $9.5 million, earning nearly $2.6 million in profit. The housing market during this time was steadily growing, though D'Antoni's home appreciated at a much higher rate. Coastal areas like Manhattan Beach have seen increased demand from cash buyers for luxury real estate.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.